Format

Send to

Choose Destination
JAMA Oncol. 2019 Jun 1. doi: 10.1001/jamaoncol.2019.1943. [Epub ahead of print]

Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients With Ovarian Cancer.

Author information

1
Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis.
2
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis.
3
Medical Student, University of Minnesota Medical School, Minneapolis.
4
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis.
PMID:
31152668
PMCID:
PMC6547254
[Available on 2020-06-01]
DOI:
10.1001/jamaoncol.2019.1943

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center